5317 related articles for article (PubMed ID: 16584284)
1. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the nonparametric estimation method in NONMEM VI.
Savic RM; Kjellsson MC; Karlsson MO
Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
[TBL] [Abstract][Full Text] [Related]
3. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.
Baverel PG; Savic RM; Wilkins JJ; Karlsson MO
J Pharmacokinet Pharmacodyn; 2009 Aug; 36(4):297-315. PubMed ID: 19572188
[TBL] [Abstract][Full Text] [Related]
5. Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.
Neely MN; van Guilder MG; Yamada WM; Schumitzky A; Jelliffe RW
Ther Drug Monit; 2012 Aug; 34(4):467-76. PubMed ID: 22722776
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model.
Gibiansky L; Gibiansky E; Bauer R
J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):17-35. PubMed ID: 22101761
[TBL] [Abstract][Full Text] [Related]
7. Approaches to handling pharmacodynamic baseline responses.
Dansirikul C; Silber HE; Karlsson MO
J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):269-83. PubMed ID: 18446428
[TBL] [Abstract][Full Text] [Related]
8. Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models.
Baverel PG; Savic RM; Karlsson MO
J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):63-82. PubMed ID: 21076858
[TBL] [Abstract][Full Text] [Related]
9. Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.
Bach T; An G
J Pharmacokinet Pharmacodyn; 2021 Aug; 48(4):581-595. PubMed ID: 33884580
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches.
Prémaud A; Weber LT; Tönshoff B; Armstrong VW; Oellerich M; Urien S; Marquet P; Rousseau A
Pharmacol Res; 2011 Mar; 63(3):216-24. PubMed ID: 21056671
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.
Kisor DF; Watling SM; Zarowitz BJ; Jelliffe RW
Clin Pharmacokinet; 1992 Jul; 23(1):62-8. PubMed ID: 1617859
[TBL] [Abstract][Full Text] [Related]
12. Population and individual minimal modeling of the frequently sampled insulin-modified intravenous glucose tolerance test.
Erichsen L; Agbaje OF; Luzio SD; Owens DR; Hovorka R
Metabolism; 2004 Oct; 53(10):1349-54. PubMed ID: 15375793
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic modelling of intravenous tobramycin in adolescent and adult patients with cystic fibrosis using the nonparametric expectation maximization (NPEM) algorithm.
Touw DJ; Vinks AA; Neef C
Pharm World Sci; 1997 Jun; 19(3):142-51. PubMed ID: 9259030
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an extended grid method for estimation using nonparametric distributions.
Savic RM; Karlsson MO
AAPS J; 2009 Sep; 11(3):615-27. PubMed ID: 19714472
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM.
Vermes A; Math t RA; van der Sijs IH; Dankert J; Guchelaar HJ
Ther Drug Monit; 2000 Dec; 22(6):676-87. PubMed ID: 11128235
[TBL] [Abstract][Full Text] [Related]
16. Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers.
Wedagedera JR; Afuape A; Chirumamilla SK; Momiji H; Leary R; Dunlavey M; Matthews R; Abduljalil K; Jamei M; Bois FY
CPT Pharmacometrics Syst Pharmacol; 2022 Jun; 11(6):755-765. PubMed ID: 35385609
[TBL] [Abstract][Full Text] [Related]
17. Performance of different population pharmacokinetic algorithms.
Colucci P; Grenier J; Yue CS; Turgeon J; Ducharme MP
Ther Drug Monit; 2011 Oct; 33(5):583-91. PubMed ID: 21912327
[TBL] [Abstract][Full Text] [Related]
18. Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.
Hooker AC; Staatz CE; Karlsson MO
Pharm Res; 2007 Dec; 24(12):2187-97. PubMed ID: 17612795
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
Wang J; Liang WQ; Wu JJ; Pan CM
Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
